ARCHIVES

Nevins Retracts Key Paper By Duke Group, Raising Question Of Harm To Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 39 | October 29, 2010

Download PDF Visit The Full Archive

Related Articles

Von Eschenbach Says He Will Step Down as NCI Director; No Acting Director Has Been Named.

March 24, 2006

Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.

January 25, 2002

NCI Audit Finds “Low Quality” Research At Calif. Foundation

June 17, 1994

Cancer Research Isn’t A Priority In Bush Budget, AACR President Says.

February 9, 2007

Seattle Panel Meeting Generate More Support For Increased Outreach Funding, Consortium Approached

November 2, 1984

Clinical Center’s Cancer Nursing Recruitment Improved

January 10, 1986